Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA committee to review Seattle Genetics cancer drug applications in July
FDA committee to review Seattle Genetics cancer drug applications in July
FDA committee to review Seattle Genetics cancer drug applications in July
Submitted by
admin
on June 16, 2011 - 10:19pm
Source:
bizjournals.com
News Tags:
FDA
Seattle Genetics
brentuximab vedotin
Headline:
FDA committee to review Seattle Genetics cancer drug applications in July
Do Not Allow Advertisers to Use My Personal information
